Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency

Jeanne Marie Perotin1 Service de Pneumologie, INSERM U1250, Hôpital Universitaire, Reims, France, [email protected]

Sylvie Leroy2 Service de Pneumologie, CHU de Nice, FHU OncoAge, Université Côte d’Azur, Nice, France

Charles Hugo Marquette2 Service de Pneumologie, CHU de Nice, FHU OncoAge, Université Côte d’Azur, Nice, France

Hervé Mal3 Service de Pneumologie, Hôpital Universitaire Bichat, Paris, France

Hervé Dutau4 Service d’Oncologie Thoracique, Maladies de la Plèvre, Pneumologie Interventionnelle, Hôpital Universitaire, Marseille, France

Arnaud Bourdin5 Département de Pneumologie et Addictologie, PhyMedExp, INSERM U1046, CNRS UMR, Hôpital Universitaire, Montpellier, France

Jean Michel Vergnon6 Service de Pneumologie, Hôpital Universitaire, Saint Etienne, France

Christophe Pison7 Clinique Universitaire de Pneumologie, Pôle Thorax et Vaisseaux, Inserm1055, Hôpital Universitaire Grenoble Alpes, Université Grenoble Alpes, Grenoble, France

Coralie Barbe8 Département de Méthodologie, Pôle Recherche-Innovations, Hôpital Universitaire, Reims, France

Gaëtan Deslee1 Service de Pneumologie, INSERM U1250, Hôpital Universitaire, Reims, France, [email protected]Correspondence[email protected]

& On behalf of the REVOLENS Study Group show all

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date